skip to main content

News and Events

Recent Releases

05/22/2024 - 12:00pm

Rogel Cancer Center Members Attend 2024 ASCO Annual Meeting

Check out the list of U-M presenters to support your colleagues. Connect with researchers on X/Twitter using #AACR24. Be sure to tag @UMRogelCancer.

05/06/2024 - 1:30pm

Haymart gets $3.3M to develop risk-based approach to thyroid cancer survivorship care

Do all thyroid cancer survivors need the same level of follow-up care and monitoring? With a new $3.3 million grant from the National Cancer Institute, Megan Haymart, M.D., will identify survivors at different risks of recurrence and develop a system for long-term monitoring based on that risk.

04/29/2024 - 4:00pm

With $5M grant, Rogel team will conduct preclinical work to develop drugs targeting cancer master regulator

University of Michigan Rogel Cancer Center researcher Arul Chinnaiyan, M.D., Ph.D., has received a $5 million grant from the J.C. Kennedy Foundation to conduct laboratory tests of a potential drug candidate targeting a master regulator that controls the majority of genes involved in the most challenging type of prostate cancer.

04/11/2024 - 4:15pm

Zhou gets $2.9M to develop a system to predict outcomes in multiple myeloma

By combining data from MRI scans and clinical tests, University of Michigan Rogel Cancer Center researcher Chuan Zhou, Ph.D., will develop a decision support tool to tailor treatment for individual patients with multiple myeloma. It’s a cancer that’s considered incurable, with survival ranging from less than a year to more than a decade, depending on the extent and aggressiveness of the tumors.

04/10/2024 - 3:45pm

AACR 2024: Rogel Recap of the 2024 AACR Annual Meeting

Highlights from Rogel's presence at the 2024 AACR Annual Meeting

All Releases

Publications